PAVmed, Inc. (PAVM)
4.68
-0.50
(-9.65%)
USD |
NASDAQ |
Jun 09, 16:00
4.80
+0.12
(+2.56%)
After-Hours: 20:00
PAVmed SG&A Expense (Quarterly) : 6.572M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | 10.43M |
| Alphatec Holdings, Inc. | 137.06M |
| SINTX Technologies, Inc. | 2.934M |
| PROCEPT BioRobotics Corp. | 65.09M |
| Abbott Laboratories | 3.74B |